Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye
AbstractBackground/Objective(s)/Introduction TURKOVAC™ is a whole-virion inactivated COVID-19 vaccine, which was developed and recently granted emergency use authorization (conditional marketing authorization) in Türkiye. The objective of this study is to assess the spectrum and the distribution of...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2023-12-01
|
| סדרה: | Annals of Medicine |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2183985 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
